|
Status |
Public on Apr 26, 2024 |
Title |
TNF-NFkB-p53 axis restricts in vivo survival of hPSC-derived dopamine neuron (CRISPR screen) |
Organism |
Homo sapiens |
Experiment type |
Other
|
Summary |
First-in-human clinical trials illustrate the feasibility and translational potential of human pluripotent stem cell (hPSC)-based cell therapy in Parkinson’s disease (PD). However, a major unresolved challenge is the extensive cell death following transplantation with <10% of grafted dopamine neurons surviving. Here, we performed a pooled CRISPR/Cas9 screen to enhance survival of postmitotic dopamine neurons in vivo. We identified TP53-mediated apoptotic cell death as major contributor to dopamine neuron loss and uncovered a causal link of TNFa-NFκB signaling in limiting cell survival. A surface marker screen enabled the purification of midbrain dopamine neurons obviating the need for genetic reporters. Combining cell sorting with adalimumab pretreatment, a clinically approved TNFa inhibitor, enabled efficient engraftment of postmitotic dopamine neurons leading to extensive re-innervation and functional recovery in a preclinical PD mouse model. Thus, transient TNFa inhibition may present a clinically relevant strategy to enhance survival of human PSC-derived lineages in PD and beyond.
|
|
|
Overall design |
CRISPR screen study of TP53 WT dopamine neurons, in vitro and in vivo
|
|
|
Contributor(s) |
Cho H, Chaudhry F, Betel D, Studer L |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Nov 02, 2022 |
Last update date |
Apr 26, 2024 |
Contact name |
Hyein Sophia Cho |
E-mail(s) |
choh@mskcc.org
|
Organization name |
Memorial Sloan Kettering Cancer Center
|
Department |
Developmental Biology
|
Street address |
430 E 67th St
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (8)
|
|
This SubSeries is part of SuperSeries: |
GSE216365 |
TNF-NFkB-p53 axis restricts in vivo survival of hPSC-derived dopamine neuron |
|
Relations |
BioProject |
PRJNA896993 |